Sanity Group, a Berlin, Germany-based medical cannabis and wellness brand, completed a €20m funding.
The round was led by Calyx, a European Cannabis-focused investment fund and HV Holtzbrinck Ventures, with participation from Karan Wadhera (managing partner at Casa Verde), Scooter Braun’s investment fund TQ Ventures and Cherry Ventures, and existing investors Atlantic Food Labs and several angel investors including the founders of the German advertising agency Heimat.
Founded in 2018 by German entrepreneurs and cannabis advocates Finn Hänsel and Fabian Friede, Sanity Group is fully licensed and currently operational with two business units, Sanatio Pharma, a medical cannabis company devoted to the development of new therapies and pharmaceuticals, and wellness brand VAAY.
The funds will be used to drive forward strategic projects to give people access to medical and medically-related cannabis products.
FinSMEs
17/02/2020